PhRMA-backed alliance says it wants to 'modernize' the 340B program. Critics say the changes will only limit access
The Alliance to Save America’s 340B Program (ASAP 340B) is made up of a coalition of biopharma stakeholders who last week released a set of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
